SEC Form 4 · accession 0001209191-18-044604
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P. Martin Paslick
Officer — SVP and CIO
Period of report
Jul 27, 2018
Accepted (ET)
Jul 31, 2018 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2018 | M | 73,125 | $37.18 | A | 83,322 | D | |
| Common Stock | Jul 27, 2018 | F | 42,059 | $124.15 | D | 41,263 | D | |
| Common Stock | holding | — | — | — | 80,330 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF1 | $37.18 | Jul 27, 2018 | M | 37,500 | D | — | Feb 6, 2023 | Common Stock | 37,500 | 0 | D |
| Stock Appreciation RightF2 | $37.18 | Jul 27, 2018 | M | 35,625 | D | — | Feb 6, 2023 | Common Stock | 35,625 | 0 | D |
Explanation of responses
- F1The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
- F2The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.